|1.||Hara, Yukihiko: 8 articles (10/2010 - 01/2003)|
|2.||Yang, Chung S: 7 articles (12/2015 - 12/2006)|
|3.||Lubet, Ronald A: 5 articles (06/2010 - 01/2006)|
|4.||You, Ming: 5 articles (06/2010 - 01/2006)|
|5.||Lee, Mao-Jung: 4 articles (01/2013 - 01/2007)|
|6.||Ahmed, Aqeel: 3 articles (12/2015 - 09/2012)|
|7.||Wang, Yian: 3 articles (06/2010 - 01/2006)|
|8.||Tawfik, H: 3 articles (01/2010 - 11/2007)|
|9.||Mescheder, A: 3 articles (01/2010 - 11/2007)|
|10.||Lu, Gang: 3 articles (08/2008 - 12/2006)|
08/01/2012 - "Polyphenon E 10% ointment was also significantly more effective than vehicle with regard to several secondary endpoints, including the complete clearance of baseline warts and partial clearance of at least 50% of all warts in both studies. "
08/01/2012 - "In two double-blind, multinational studies in adults with external genital and perianal warts, polyphenon E 10% ointment for up to 16 weeks was significantly more effective than vehicle with regard to the complete clearance of all warts (i.e. "
03/01/2011 - "Regarding primary outcome, both Polyphenon E 15% and 10% demonstrated significantly higher likelihood of complete clearance of baseline and baseline and new warts compared with controls. "
06/01/2008 - "About 53% of patients treated with Polyphenon E 15% ointment showed complete clearance of all baseline and new anogenital warts, 51% for Polyphenon E 10% ointment, and 37% for vehicle (P = 0.01 and P = 0.03, respectively; two-sided Fisher's exact test; intent-to-treat population, last observation carried forward analysis). "
01/01/2010 - "Polyphenon E: a new treatment for external anogenital warts."
01/01/2006 - "We found that treatment with polyphenon E exhibited a significant reduction on both tumor multiplicity and tumor load (tumor multiplicity x tumor volume) in a dose-dependent fashion. "
06/01/2009 - "With a relatively low dose level (4.19 mg/kg), Polyphenon E decreased tumor multiplicity by 53%, whereas Polyphenon E without EGCG at the same dose failed to inhibit lung carcinogenesis. "
01/01/2006 - "Polyphenon E (2% wt/wt) in the diet reduced tumor multiplicity by 46% and tumor load by 94%. "
01/01/2003 - "Genotoxicity and toxicity of the potential cancer-preventive agent polyphenon E."
03/01/2013 - "In therapeutic models of neuroblastoma in A/J, but not in immunodeficient NOD/SCID mice, Polyphenon E inhibited tumor growth by acting on myeloid-derived suppressor cells (MDSC) and CD8 T cells. "
|3.||Condylomata Acuminata (Genital Wart)
11/01/2007 - "A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts."
07/01/2014 - "Sinecatechins (Polyphenon E) ointment for treatment of external genital warts and possible future indications."
06/01/2012 - "The use of sinecatechins (polyphenon E) ointment for treatment of external genital warts."
01/01/2008 - "With the development of Polyphenon E 15% ointment, progress has been made towards optimized, patient-friendly treatment of genital warts. "
11/01/2007 - "Intervention(s) Topical application of Polyphenon E 10% Cream, Polyphenon E 15% Ointment or placebo to all external genital warts three times a day. "
|4.||Prostatic Neoplasms (Prostate Cancer)
04/01/2014 - "Our findings provide additional evidence for the safety and chemopreventive effect of Polyphenon E in preventing metastatic progression of prostate cancer."
04/01/2014 - "Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice."
07/01/2009 - "These findings support a potential role for Polyphenon E in the treatment or prevention of prostate cancer."
02/01/2012 - "Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities."
04/01/2014 - "Polyphenon E is an effective chemopreventive agent in preventing the progression of prostate cancer to metastasis in TRAMP mice. "
|5.||B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/15/2013 - "Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia."
08/10/2009 - "Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia."
08/10/2009 - "To define the optimal dose of Polyphenon E for chronic daily administration and tolerability in patients with chronic lymphocytic leukemia (CLL). "
01/15/2013 - "The objective of the current study was to follow up the results of phase 1 testing by evaluating the clinical efficacy of the green tea extract Polyphenon E for patients with early stage chronic lymphocytic leukemia (CLL). "
|5.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|8.||Catechin (Z 7300)
|9.||epigallocatechin gallate (epigallocatechin-3-gallate)
|2.||Prostatectomy (Retropubic Prostatectomy)